Literature DB >> 8883497

Insulin resistance and coronary heart disease.

M Laakso1.   

Abstract

Insulin resistance and hyperinsulinaemia often occur with many cardiovascular risk factors. Whether hyperinsulinaemia and insulin resistance are risk factors for coronary heart disease is still a matter of debate. The information from prospective population studies, in which the relationship between hyperinsulinaemia and coronary heart disease has been investigated, is summarized. The possibility that hyperinsulinaemia and insulin resistance increase the risk for coronary heart disease will be approached from two angles. Evidence is presented of how hyperinsulinaemia and insulin resistance increase the risk for coronary heart disease indirectly through their effects on cardiovascular risk factors. Finally, evidence of how hyperinsulinaemia and insulin resistance could directly promote atherosclerosis is reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883497     DOI: 10.1097/00041433-199608000-00008

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  19 in total

1.  Cardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: project SuGAR.

Authors:  Kelly J Hunt; Emily Kistner-Griffin; Ida Spruill; Abeba A Teklehaimanot; W Timothy Garvey; Michèle Sale; Jyotika Fernandes
Journal:  South Med J       Date:  2014-10       Impact factor: 0.954

Review 2.  Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.

Authors:  K Huber
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

3.  Subclinical atherosclerosis and metabolic risk: role of body mass index and waist circumference.

Authors:  Sarah M Camhi; Peter T Katzmarzyk; Stephanie T Broyles; Sathanur R Srinivasan; Wei Chen; Claude Bouchard; Gerald S Berenson
Journal:  Metab Syndr Relat Disord       Date:  2010-12-06       Impact factor: 1.894

4.  Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioning.

Authors:  Xuxia Wu; Amit Patki; Cristina Lara-Castro; Xiangqin Cui; Kui Zhang; R Grace Walton; Michael V Osier; Gary L Gadbury; David B Allison; Mitchell Martin; W Timothy Garvey
Journal:  J Appl Physiol (1985)       Date:  2010-11-25

Review 5.  Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.

Authors:  J Plutzky
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

Review 6.  Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?

Authors:  Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal study.

Authors:  Nancy A West; Mary N Haan; Hal Morgenstern
Journal:  Neurobiol Aging       Date:  2008-07-17       Impact factor: 4.673

Review 8.  Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?

Authors:  Markku Laakso
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 9.  Insulin resistance and hyperglycaemia in cardiovascular disease development.

Authors:  Markku Laakso; Johanna Kuusisto
Journal:  Nat Rev Endocrinol       Date:  2014-03-25       Impact factor: 43.330

10.  Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.